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Abstract
Three antimicrobial peptides, which had strong antimicrobial activity against a broad spectrum of microorganisms, were
isolated from the stomach of the bullfrog, Rana catesbeiana. Two of the antimicrobial peptides were found to be derived from
the N-terminal sequences of pepsinogen A and C prosequences. The amino acid sequences of the new antimicrobial peptides,
named bullfrog pepsinogen A-derived antimicrobial peptide (bPaAP) and bullfrog pepsinogen C-derived antimicrobial
peptide (bPcAP), were Gly-Val-Val-Lys-Val-Ser-Arg-Leu-Lys-Gly-Glu-Ser-Leu-Arg-Ala-Arg-Leu (MW 1865.5) and Ile-Ile-
Lys-Val-Pro-Leu-Lys-Lys-Phe-Lys-Ser-Met-Arg-Glu-Val-Met-Arg-Asp-His-Gly-Ile-Lys-Ala-Pro-Val-Val-Asp-Pro-Ala-Th-
r-Lys-Tyr (MW 3691.6), respectively. The bPaAP and bPcAP adopted 35% and 42% amphipathic K-helical structure in 50%
trifluoroethanol, respectively, and were non-hemolytic up to a concentration of 200 Wg/ml. Synthesized pepsinogen C
prosequences of monkey and human, which had similar structural characteristics as bPaAP and bPcAP, also showed
antimicrobial activity at concentrations of 10^200 Wg/ml. The third peptide was buforin I, previously found in the stomach of
the Asian toad, Bufo bufo gargarizans. These findings strongly suggest that peptides derived from the prosequences of
pepsinogens, along with buforin I, may contribute to the antimicrobial function of the gastrointestinal mucosa of vertebrates,
including human. z 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
Living organisms are endowed with an innate im-
munity consisting of various antimicrobial peptides
against invading microorganisms [1]. Many di¡erent
families of antimicrobial peptides, which were classi-
¢ed based on the amino acid sequence and secondary
structure, have been isolated from insects, plants,
animals, and microorganisms [2,3]. Among these
antimicrobial peptides, those from the mucosal epi-
thelia of the reproductive, respiratory, and gastroin-
testinal systems of vertebrates have attracted increas-
ing interest, since the incidence of infectious disease
on the mucosal surfaces is rare despite a continuous
exposure to a wide variety of pathogenic microor-
ganisms [4]. These peptides include andropin, a ce-
cropin-related peptide from the reproductive tract of
Drosophila [5] ; magainin, a peptide from granular
glands of skin and gastrointestinal mucosa of Xeno-
pus laevis [6,7]; tracheal antimicrobial peptide, a pep-
tide from mammalian respiratory mucosa [8]; and
enteric defensins, peptides from mammalian intesti-
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nal mucosa [9]. Recently, human L-defensins were
found to be related with epithelial diseases, as evi-
denced by cystic ¢brosis [10] and lesional psoriatic
skin [11].
In addition, other antimicrobial peptides, derived
from larger polypeptides already known for other
functions, have been isolated and characterized [3].
For instance, the precursor fragments of peptide hor-
mones such as xenopsin and caerulin were isolated
from the skin and stomach of Xenopus laevis [7,12];
GIP(7^42) and DBI(32^86), which were derived from
the gastric inhibitory polypeptide and diazepam-
binding inhibitor, respectively, were isolated from
pig intestine [13]; and buforin I, which was derived
from histone H2A, was isolated from the stomach of
the Asian toad, Bufo bufo gargarizans [14]. Host-de-
fense functions of these peptide fragments from larg-
er polypeptides have been suggested, but their actual
roles in vivo remain to be elucidated [3]. Recently,
small antimicrobial peptides with homopolymeric re-
gions of Asp were isolated from ovine pulmonary
surfactant [15]. These peptides were known as parts
of prosequences of some zymogens such as trypsino-
gen and conserved among a number of animal spe-
cies [16,17]. In addition, synthetic fragments of ovine
trypsinogen prosequence and X. laevis PYL prose-
quence, both containing homopolymeric regions of
Asp, had antimicrobial activity in addition to their
possible role in neutralization of the cationic charge
of the active protein during synthesis [18].
In this report, we describe the isolation and prop-
erties of the two antimicrobial peptides derived from
the prosequences of pepsinogen A and C in the stom-
ach of the bullfrog, Rana catesbeiana. In addition, an
N-terminal 39-amino acid fragment of histone H2A,
previously named buforin I [14,19], was also isolated
and characterized from the stomach of the bull-
frog.
2. Materials and methods
2.1. Peptide puri¢cation
Antimicrobial peptides were puri¢ed from the
stomach of the bullfrog (R. catesbeiana) by the meth-
od described by Park et al. [14] with an additional
chromatographic step. The stomachs (tissue weight,
100 g) were removed from 25 adult bullfrogs (both
male and female), obtained from a Korean bullfrog
farm, and homogenized using a PowerGen 700 ho-
mogenizer (Fisher, NJ) in 2 l of acidic medium (1%
(v/v) tri£uoroacetic acid (TFA), 1 M HCl, 5% (v/v)
formic acid, 1% (w/v) NaCl, and pepstatin A at 10
Wg/ml). The homogenate was centrifuged at
20 000Ug for 30 min in a Himac SCR20BR (Hitachi,
Tokyo, Japan) and the supernatant was then applied
to reverse-phase concentration using a Sep-Pak C18
cartridge (Millipore, Milford, MA) which was acti-
vated with 80% acetonitrile containing 0.1% (v/v)
TFA and £ushed with 0.1% (v/v) TFA to remove
the excess acetonitrile. After being loaded with the
supernatant, the cartridge was washed with 20 ml of
0.1% (v/v) TFA and the peptides trapped in the Sep-
Pak C18 cartridge were eluted with 6 ml of 80% (v/v)
acetonitrile containing 0.1% (v/v) TFA. The eluate
was then lyophilized and subsequently resuspended
in 10 ml of 0.01 M Tris-HCl (pH 7.5), containing
0.01 M NaCl. The resuspended eluate was loaded
onto a 2.5U10 cm heparin-Sepharose column (Phar-
macia, Uppsala, Sweden) equilibrated with 0.01 M
Tris-HCl (pH 7.5), containing 0.01 M NaCl. The
bound peptides were eluted by a stepwise gradient
of 0.1 M, 0.5 M and 1 M NaCl, and concentrated
by the Sep-Pak C18 cartridge. 5 Wl of each sample
was then assayed for antimicrobial activity against
Bacillus subtilis and Escherichia coli. The active elu-
ates were run on a C18 reverse-phase high-perform-
ance liquid chromatography (HPLC) column
(3.9U300 mm, Delta-Pak, Millipore). The peptides
loaded into the column were eluted with a linear
gradient of 0^50% in 1 h at a £ow rate of 1 ml/min
with bu¡er A (0.1% TFA in H2O) and bu¡er B (0.1%
TFA in acetonitrile). The eluates were monitored by
measuring the absorbance at 214 nm. Each fraction
was dried under vacuum and resuspended in H2O.
5 Wl of the resuspended peptides was assayed for
antimicrobial activity. The active fraction was further
puri¢ed on a cation-exchange HPLC column
(7.5U75 mm, Protein-Pak SP-5PW, Millipore). The
elution was performed with a linear gradient of 0^
100% in 1 h of 0.3 ml/min with bu¡er C (50 mM
Tris-HCl, pH 7.0) and bu¡er D (50 mM Tris-HCl,
pH 7.0 containing 1 M NaCl). The purity of the
isolated peptide was assessed by reverse-phase
HPLC, Tricine SDS-PAGE, and matrix-associated
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laser desorption ionization (MALDI) mass spectro-
scopy (Kratos Kompact MALDI, Manchester, UK).
2.2. Antimicrobial assays
Antimicrobial activity was examined during each
puri¢cation step by the radial di¡usion assay on B.
subtilis lawn as described by Lehrer et al. [20]. 20 ml
culture of B. subtilis cells in the mid-logarithmic
phase was washed with cold 10 mM sodium phos-
phate bu¡er, pH 7.4 (NAPB) and resuspended in 10
ml of cold NAPB. A volume containing 1U106 bac-
terial CFU was added to 6 ml of underlayer agar (10
mM sodium phosphate, 1% (v/v) trypticase soy
broth, 1% agarose, pH 6.5) and the mixture was
poured into a Petri dish. Samples were added directly
to the 3-mm wells that were made on the solidi¢ed
underlayer agar. After incubation at 37‡C for 3 h,
the underlayer agar was covered with a nutrient-rich
top agar overlay and incubated overnight at 37‡C.
Antimicrobial activity was determined by observing
the zone of suppression of bacterial growth around
Fig. 1. Puri¢cation of antimicrobial peptides. Two active fractions eluted with 0.1 M NaCl (A) and 0.5 M NaCl (C) from a heparin-
Sepharose column were loaded on a 3.9U300 mm Delta-Pak C18 column and fractionated with a linear gradient (dashed line) of 0^
50% acetonitrile in 0.1% TFA. The active peaks, which are indicated by the arrows, were further separated on a 7.5U75 mm Protein-
Pak SP-SPW cation-exchange HPLC column. The puri¢ed peptides, named bPaAP, bullfrog buforin I (Buf), and bPcAP (see Section
3), were analyzed by tricine SDS-PAGE (B, D). Lane M represents the size marker.
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the 3-mm wells. The minimal inhibitory concentra-
tions (MICs) of the isolated and synthetic peptides
against several Gram-positive and Gram-negative
bacteria and fungi were determined as described by
Park et al. [14]. The lowest concentration of antimi-
crobial peptide which showed visible suppression of
growth was de¢ned as the MIC.
2.3. Molecular weight determination and sequence
analysis of the antimicrobial peptides
Molecular weight of the antimicrobial peptide was
determined by MALDI mass spectroscopy. Approx-
imately 20 nmol of lyophilized peptide was dissolved
in 50% (v/v) acetonitrile containing 7% (w/v) sina-
pinic acid and mixed with a Pt probe. After removing
the solvent in warm air, the peptide, adsorbed to the
Pt probe, was applied to a vacuum chamber and
analyzed. Amino acid sequencing was performed by
the automated Edman degradation method on an
Applied Biosystems gas phase sequencer, Model
477A (Foster City, CA).
2.4. Quanti¢cation of peptides
The amounts of peptides were determined by ami-
no acid analysis. The lyophilized peptides were hy-
drolyzed in 6 N HCl at 110‡C for 24 h and converted
to their phenylthiocarbamyl derivatives. Samples
were then analyzed using a Pico-tag analysis system
on a Beckman 121 MB amino acid analyzer (Fuller-
ton, CA).
2.5. Peptide synthesis
Peptides were synthesized by the solid-phase syn-
thesis method on a Milligen 9050 Pepsynthesizer ac-
cording to £uoren-9-methyloxycarbonyl (Fmoc)-pol-
ypeptide active ester chemistry. The synthesized
peptides were puri¢ed by reverse-phase HPLC and
the purities were con¢rmed by amino acid analysis
and MALDI mass spectroscopy.
2.6. Hemolysis assay
Hemolytic activity was assayed as described by
Aboudy et al. [21] with a slight modi¢cation. 3 ml
of freshly prepared human erythrocytes [22] was
washed with isotonic phosphate-bu¡ered saline, pH
7.4 (PBS), until the color of the supernatant turned
clear. The washed erythrocytes were then diluted to a
¢nal volume of 20 ml with the same bu¡er. To 190 Wl
of the cell suspension in microfuge tubes, peptide
samples (10 Wl), serially diluted in PBS, were added.
Following gentle mixing, the tubes were incubated at
37‡C for 30 min and then centrifuged at 4000Ug for
5 min. 100 Wl of supernatant was taken, diluted to
1 ml with PBS, and absorbance at 567 nm was de-
termined. The relative optical density, as compared
with that of the cell suspension treated with 0.2%
Triton X-100, was de¢ned as % hemolysis.
2.7. Circular dichroism (CD)
CD spectra were measured in either 50 mM
NAPB, or 50% (v/v) tri£uoroethanol (TFE) in
50 mM NAPB, on a Jasco model J-715 spectropol-
arimeter with a cell path length of 1 mm. Five scans
per sample were performed over the wavelength
range 200^250 nm [23]. The contents of K-helix, L-
sheet and unordered structures were estimated as de-
scribed by Yang et al. [24].
Table 1
Amino acid compositions of the isolated peptides
Residue bPaAP bPcAP Bullfrog buforin I
Aspartic acid 0 2.09 (2) 0
Glutamic acid 1.31 (1) 1.24 (1) 0
Asparagine 0 0 1.28 (1)
Glutamine 0 0 1.82 (2)
Serine 2.04 (2) 1.00 (1) 2.89 (3)
Glycine 1.77 (2) 1.04 (1) 6.64 (7)
Histidine 0 0.84 (1) 1.31 (1)
Arginine 2.85 (3) 1.79 (2) 7.30 (7)
Threonine 0 1.01 (1) 1.02 (1)
Proline 0 3.24 (3) 1.27 (1)
Alanine 1.21 (1) 2.01 (2) 3.49 (3)
Tyrosine 0 0.49 (1) 1.38 (1)
Valine 2.62 (3) 3.58 (4) 2.23 (3)
Methionine 0 1.81 (2) 0
Isoleucine 0 2.28 (3) 0
Leucine 2.84 (3) 1.29 (1) 2.76 (3)
Phenylalanine 0 1.20 (1) 0.93 (1)
Tryptophan 0 0 0
Lysine 2.22 (2) 6.78 (6) 4.64 (5)
Total 17 32 39
Numbers in parentheses indicate residues determined by se-
quence analysis.
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3. Results
3.1. Puri¢cation of antimicrobial peptides
The whole stomachs were homogenized in an
acidic medium containing 10 Wg/ml of an aspartic
protease inhibitor, pepstatin A. The extracts, which
showed antimicrobial activity against B. subtilis and
E. coli, were fractionated on a heparin-Sepharose
column. Two active eluates collected from the hepa-
rin-Sepharose column were subjected to reverse-
phase HPLC and three peaks showing strong anti-
microbial activity were obtained (Fig. 1A,C). These
were further puri¢ed by a cation-exchange HPLC
and second reverse-phase separation. Three antimi-
crobial peptides with over 95% purity as determined
by reverse-phase HPLC, tricine SDS-PAGE, and
MALDI mass spectroscopy were subjected to amino
acid and peptide sequence analyses.
3.2. Primary structure determination
Three isolated peptides were identi¢ed by amino
acid analysis (Table 1), MALDI mass spectroscopy
(Fig. 2), and peptide sequence analysis (Fig. 3). Two
of the isolated peptides were the N-terminal 17-resi-
due and 32-residue fragments of the prosequences of
pepsinogen A [25] and pepsinogen C [26], which were
named bPaAP and bPcAP, respectively (Fig. 3). The
third peptide was a 39-amino acid peptide, buforin I
(Fig. 3), which had been previously isolated from the
stomach of the Asian toad [14]. The total amounts of
Fig. 2. Mass spectroscopic analysis of the isolated peptides. Masses for bPaAP, bPcAP, and buforin I were determined by MALDI
mass spectroscopy.
Fig. 3. Amino acid sequences of the isolated and synthetic anti-
microbial peptides. The amino acid residues are shown by sin-
gle letter codes. The numbering starts from the N-terminus of
each peptide. The whole sequences of the isolated and synthetic
prosequences of each pepsinogen, which were identi¢ed by Ed-
man degradation, are underlined. The arrows indicate the cleav-
age sites of each pepsinogen. The X represents an unidenti¢ed
amino acid residue.
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puri¢ed bPaAP, bPcAP, and buforin I were 15, 60,
and 50 Wg per g wet tissue of bullfrog stomach, re-
spectively. The amino acid composition of the
peptides (Table 1), analyzed by the acid hydrolysis
method, and its molecular weight determined by
MALDI mass spectroscopy (Fig. 2) were consistent
with those obtained from the amino acid sequences
(Fig. 3). These results indicate that post-translational
modi¢cations were not present in the isolated pep-
tides.
3.3. Antimicrobial activity of the isolated peptides and
synthetic peptides
The isolated peptides were assessed for their anti-
microbial activity on three Gram-positive (B. subtilis,
Staphylococcus aureus, and Streptococcus mutans)
and four Gram-negative bacteria (E. coli, Pseudomo-
nas putida, Salmonella typhimurium, and Serratia
sp.), and three fungi (Candida albicans, Saccharomy-
ces cerevisiae, and Cryptococcus neoformans). As
shown in Table 2, MICs of bPaAP and bPcAP
were in the range of 6^20 Wg/ml, depending on the
test microorganism. MICs of buforin I from bullfrog
were identical to those of toad buforin I. To examine
the antimicrobial activity of the pepsinogen prose-
quences of other species, we synthesized two peptides
based on the prosequences of monkey [27] and hu-
man pepsinogen C [28], which were designated mon-
key pepsinogen C-derived antimicrobial peptide
(mPcAP) and human pepsinogen C-derived antimi-
crobial peptide (hPcAP), respectively (Fig. 3). Both
mPcAP and hPcAP were reported to be released dur-
ing the activation of each pepsinogen at acidic pH
[27,28]. The mPcAP and hPcAP also displayed a
broad spectrum of antimicrobial activity, even
Table 2
Antimicrobial activity of the isolated and synthetic antimicrobial peptides
Microorganism Minimal inhibitory concentrationa (Wg/ml)
bPaAP bPcAP Bullfrog buforin I mPcAP hPcAP Toad buforin I Magainin 2
Gram-positive
Bacillus subtilis 6 6 4 20 50 4 50
Staphylococcus aureus 20 6 4 50 100 4 50
Streptococcus mutans 6 6 8 30 50 8 100
Gram-negative
Escherichia coli 10 10 8 50 50 8 100
Pseudomonas putida 10 6 4 100 100 4 50
Salmonella typhimurium 10 6 4 30 20 4 25
Serratia sp. 20 10 8 50 200 8 50
Fungi
Candida albicans 10 10 4 100 100 4 25
Saccharomyces cerevisiae 6 6 4 10 12 4 12
Cryptococcus neoformans 6 6 4 40 100 4 25
aMinimal inhibitory concentration was determined by the radial di¡usion assay as described in Section 2.
Table 3
Hemolytic activity of the isolated and synthetic peptides, magainin 2, and mellitin
Concentration (Wg/ml) % Hemolysis of human erythrocytes
bPaAP bPcAP mPcAP hPcAP Magainin 2 Mellitin
5 0 0 0 0 0.19 45.90
10 0 0 0 0 0.19 65.12
25 0.13 0.11 0.12 0.14 0.57 83.64
50 0.21 0.17 0.16 0.23 0.95 92.85
100 0.41 0.36 0.37 0.49 1.14 99.23
200 0.42 0.36 0.40 0.49 1.79 99.37
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though their MICs were much lower than those of
the bPaAP and bPcAP (Table 2).
3.4. Hemolysis assay of the isolated and synthetic
peptides
Hemolytic activity of two bullfrog peptides,
bPaAP and bPcAP, and two synthetic peptides,
mPcAP and hPcAP, was tested against human eryth-
rocytes. All four peptides had no appreciable hemo-
lytic activity up to 200 Wg/ml (Table 3).
3.5. Circular dichroism
Two bullfrog peptides, bPaAP and bPcAP, and
two synthetic peptides, mPcAP and hPcAP, assumed
an amphipathic K-helical structure as shown in their
Edmundson wheel projections (Fig. 4A). The CD
spectral analysis of these peptides showed that they
were unordered in aqueous solution but became
structured in the presence of 50% TFE, exhibiting
high K-helical contents (Fig. 4B). The helix values
ranged from 35 to 53%, i.e. 35% (bPaAP), 42%
(bPcAP), and 53% (hPcAP). However, the CD
spectrum of the mPcAP showed that it was unor-
dered even in the presence of 50% TFE (data not
shown).
4. Discussion
Three antimicrobial peptides have been found in
the stomach of the bullfrog, R. catesbeiana. Compar-
ison of the amino acid sequences of the peptides with
those in the GenBank/EMBL Data Bank revealed
that one of the isolated peptides was the buforin I
already reported by Park et al. [14] and the other
two, bPaAP and bPcAP, were the N-terminal frag-
Fig. 4. Edmundson wheel projections and CD spectra of bPcAP and hPcAP. (A) The Edmundson wheel projections show the amphi-
pathic structures of bPcAP and hPcAP. The N-terminal 1^18 regions of both peptides can be ¢tted to well-behaved amphipathic
K-helical structures. Polar residues are indicated as closed circles and hydrophobic residues are indicated as open circles. (B) CD spec-
tra of bPcAP and hPcAP in 50 mM NAPB in the absence or the presence of TFE. The concentrations of bPcAP and hPcAP were
9 and 12 WM, respectively. Measurements were taken in 50 mM NAPB in the absence (dashed line) or in the presence (solid line) of
50% TFE.
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ments of pepsinogen A [25] and C [26], respectively.
Pepsinogen is the precursor form of pepsin, which is
a typical aspartic protease normally present in the
gastric mucosa of vertebrates ranging from man to
¢sh. There are three major types of pepsinogens,
pepsinogen A, pepsinogen C (progastricsin), and pro-
chymosin (neonatal pepsinogen), and they are di¡er-
ent from each other in their enzymatic features and
primary structures [29]. Pepsinogens are secreted into
the gastric lumen and activated autocatalytically to
pepsins under the acidic condition, releasing the N-
terminal prosequences [30,31]. So far, the released
prosequences of pepsinogens are known to have no
signi¢cant functions of their own, even though the
prosequences of pepsinogens have the role of inacti-
vating the proteolytic activity of pepsins by blocking
access to the catalytic site for the substrates. Here,
we report a novel function of prosequences of pep-
sinogens. Both bPaAP and bPcAP, which were the
N-terminal 17-residue fragment of bullfrog pepsino-
gen A and the N-terminal 32-residue fragment of
bullfrog pepsinogen C, respectively, showed strong
antimicrobial activity against various microorgan-
isms (Table 2). Since primary structures of the pro-
sequences of each type of pepsinogen are highly con-
served among species, it is possible that pepsinogen
prosequences of other species may also have antimi-
crobial activity. To examine the antimicrobial activ-
ity of other species’ pepsinogen prosequences, we
synthesized two peptide fragments, mPcAP and
hPcAP, which were the prosequences derived from
monkey and human pepsinogen C, respectively
[27,28]. Both mPcAP and hPcAP showed comparable
antimicrobial activity to those of synthetic magainin
II, even though the activity was weaker than those of
bPaAP and bPcAP (Table 2). One of the major char-
acteristics of pepsinogen prosequences is that they
are highly basic (+4 to +9) and contain many hydro-
phobic amino acid residues. The Edmundson wheel
projections (Fig. 4A) indicate the amphipathic K-hel-
ical structures of the isolated and synthetic prose-
quences. The predicted K-helical structures were sup-
ported by CD spectral analyses (Fig. 4B). While CD
spectra of these peptides in aqueous environment
were characteristic of a mostly random structure, in
the presence of the helix-inducing solvent, tri£uoro-
ethanol, they had 35^53% K-helical content, except
mPcAP which exhibited an unordered structure.
Based on the structural features of the peptide frag-
ments of pepsinogens, we suggest that these peptides
belong to one major group of antimicrobial peptides:
the amphipathic K-helical peptides without cysteine
[3]. In addition, they did not lyse human erythro-
cytes, suggesting that they are selective to microor-
ganisms.
The third peptide was identical to buforin I, an N-
terminal 39-amino acid peptide of histone H2A, pre-
viously isolated from the stomach of the Asian toad,
except for one amino acid at the N-terminus [14].
Since the N-terminal part of histone H2A, which
comprises buforin I, is highly conserved among ver-
tebrates, it seems that the congeners of buforin I are
likely to be present in the stomach of other verte-
brates. We con¢rmed that buforin I also existed in
the stomach of the bullfrog and antimicrobial activ-
ity was identical to that of the toad buforin I (Table
2).
In this study, we describe the isolation and the
properties of three antimicrobial peptides in the
stomach of the bullfrog, R. catesbeiana. Interestingly,
all the peptides are derived from larger polypeptides,
pepsinogens and histone H2A, which have other
known functions. Recently, the antimicrobial pep-
tides, which have been derived from large proteins,
have been isolated and characterized [7,12,13]. Espe-
cially, parts of prosequences of other zymogens,
which consist of homopolymeric regions of Asp,
were isolated from an ovine pulmonary surfactant
and found to have antimicrobial activity [15]. These
homopolymeric regions of Asp, which were known
as parts of prosequences of group I serine proteases
such as trypsinogen [16,17], some prohormones such
as X. laevis PYL [32,33], and prodefensins [34], were
conserved among a number of animal species [16,17].
In addition, the synthetic fragments of ovine trypsi-
nogen prosequence and X. laevis PYL prosequence,
both containing homopolymeric regions of Asp, had
antimicrobial activity in addition to their possible
role in neutralization of the cationic charge of the
active protein during synthesis [18]. It seems that
the peptide fragments derived from prosequences of
pepsinogens and histone H2A may play an impor-
tant role in the gastrointestinal immunity of verte-
brates, including human. We think this is the ¢rst
evidence to show that pepsinogen prosequences are
involved in the vertebrate defense system.
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